Ananzo Official shared a health update after major surgery, expressing gratitude and sparking reactions from fans across social media following his procedure.

Anifrolumab, a type I interferon receptor antagonist, is already approved as an intravenous (IV) therapy for SLE. The TULIP-SC trial was designed to evaluate whether a weekly subcutaneous (SC) ...

YolTech Therapeutics, a late clinical-stage biotechnology company developing in vivo gene editing therapies, today announced positive interim data from an investigator-initiated trial (IIT) of ...

Mr. Pickles, a boxer, received VetStem Cell Therapy in conjunction with surgery for torn cruciate ligaments. This ...

BACKGROUND: The entrance of naive T cells into lymph nodes (LNs) is a crucial step for induction of heart transplant acceptance under costimulatory blockade. Specialized blood vessels within the LN ...